HEADER OXIDOREDUCTASE 29-FEB-12 4DZ5 TITLE W227F ACTIVE SITE MUTANT OF AKR1C3 COMPND MOL_ID: 1; COMPND 2 MOLECULE: ALDO-KETO REDUCTASE FAMILY 1 MEMBER C3; COMPND 3 CHAIN: A; COMPND 4 SYNONYM: 17-BETA-HYDROXYSTEROID DEHYDROGENASE TYPE 5, 17-BETA-HSD 5, COMPND 5 3-ALPHA-HSD TYPE II, BRAIN, 3-ALPHA-HYDROXYSTEROID DEHYDROGENASE TYPE COMPND 6 2, 3-ALPHA-HSD TYPE 2, CHLORDECONE REDUCTASE HOMOLOG HAKRB, COMPND 7 DIHYDRODIOL DEHYDROGENASE 3, DD-3, DD3, DIHYDRODIOL DEHYDROGENASE COMPND 8 TYPE I, HA1753, INDANOL DEHYDROGENASE, PROSTAGLANDIN F SYNTHASE, COMPND 9 PGFS, TESTOSTERONE 17-BETA-DEHYDROGENASE 5, TRANS-1,2-DIHYDROBENZENE- COMPND 10 1,2-DIOL DEHYDROGENASE; COMPND 11 EC: 1.-.-.-, 1.1.1.213, 1.1.1.112, 1.1.1.188, 1.1.1.63, 1.1.1.64, COMPND 12 1.3.1.20; COMPND 13 ENGINEERED: YES; COMPND 14 MUTATION: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: AKR1C3, DDH1, HSD17B5, KIAA0119, PGFS; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 8 EXPRESSION_SYSTEM_STRAIN: BL21(DE3); SOURCE 9 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 10 EXPRESSION_SYSTEM_PLASMID: PET21B KEYWDS TIM BARREL, OXIDOREDUCTASE EXPDTA X-RAY DIFFRACTION AUTHOR C.J.SQUIRE,Y.YOSAATMADJA,J.U.FLANAGAN REVDAT 2 13-SEP-23 4DZ5 1 REMARK SEQADV REVDAT 1 06-MAR-13 4DZ5 0 JRNL AUTH C.J.SQUIRE,Y.YOSAATMADJA,S.PARK,W.KO,C.GUISE,J.SMAILL, JRNL AUTH 2 A.PATTERSON,J.U.FLANAGAN JRNL TITL VALIDATING PR-104A BINDING TO AKR1C3 JRNL REF TO BE PUBLISHED JRNL REFN REMARK 2 REMARK 2 RESOLUTION. 1.70 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.6.0117 REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.70 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 53.53 REMARK 3 DATA CUTOFF (SIGMA(F)) : NULL REMARK 3 COMPLETENESS FOR RANGE (%) : 100.0 REMARK 3 NUMBER OF REFLECTIONS : 38655 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.176 REMARK 3 R VALUE (WORKING SET) : 0.175 REMARK 3 FREE R VALUE : 0.194 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.000 REMARK 3 FREE R VALUE TEST SET COUNT : 2038 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 1.70 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 1.74 REMARK 3 REFLECTION IN BIN (WORKING SET) : 2606 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 100.0 REMARK 3 BIN R VALUE (WORKING SET) : 0.2270 REMARK 3 BIN FREE R VALUE SET COUNT : 145 REMARK 3 BIN FREE R VALUE : 0.2520 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 2416 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 73 REMARK 3 SOLVENT ATOMS : 186 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 17.20 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 16.72 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 0.53000 REMARK 3 B22 (A**2) : -0.52000 REMARK 3 B33 (A**2) : -0.01000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): 0.095 REMARK 3 ESU BASED ON FREE R VALUE (A): 0.089 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.053 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 2.890 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.955 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.948 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 2612 ; 0.024 ; 0.020 REMARK 3 BOND LENGTHS OTHERS (A): NULL ; NULL ; NULL REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 3552 ; 2.311 ; 1.996 REMARK 3 BOND ANGLES OTHERS (DEGREES): NULL ; NULL ; NULL REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 321 ; 5.877 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 117 ;36.470 ;23.846 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 437 ;11.793 ;15.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 16 ;10.828 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 393 ; 0.186 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 1972 ; 0.015 ; 0.021 REMARK 3 GENERAL PLANES OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION OTHERS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : 1 REMARK 3 REMARK 3 TLS GROUP : 1 REMARK 3 NUMBER OF COMPONENTS GROUP : 1 REMARK 3 COMPONENTS C SSSEQI TO C SSSEQI REMARK 3 RESIDUE RANGE : A 4 A 321 REMARK 3 ORIGIN FOR THE GROUP (A): 7.2980 -5.5940 -11.5220 REMARK 3 T TENSOR REMARK 3 T11: 0.0164 T22: 0.0034 REMARK 3 T33: 0.0198 T12: 0.0021 REMARK 3 T13: 0.0131 T23: 0.0035 REMARK 3 L TENSOR REMARK 3 L11: 0.6003 L22: 1.1728 REMARK 3 L33: 1.7714 L12: 0.0035 REMARK 3 L13: -0.0699 L23: -0.7574 REMARK 3 S TENSOR REMARK 3 S11: -0.0230 S12: 0.0125 S13: 0.0323 REMARK 3 S21: -0.0915 S22: -0.0398 S23: -0.1319 REMARK 3 S31: 0.0077 S32: 0.0047 S33: 0.0628 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : MASK REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.20 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: HYDROGENS HAVE BEEN USED IF PRESENT IN REMARK 3 THE INPUT REMARK 4 REMARK 4 4DZ5 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 05-MAR-12. REMARK 100 THE DEPOSITION ID IS D_1000070965. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 15-NOV-11 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 7.55 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : AUSTRALIAN SYNCHROTRON REMARK 200 BEAMLINE : MX1 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.000 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC QUANTUM 4 REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : SCALA REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 40759 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.700 REMARK 200 RESOLUTION RANGE LOW (A) : 97.260 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 0.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 100.0 REMARK 200 DATA REDUNDANCY : 29.30 REMARK 200 R MERGE (I) : 0.11800 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 25.4000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.70 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.79 REMARK 200 COMPLETENESS FOR SHELL (%) : 100.0 REMARK 200 DATA REDUNDANCY IN SHELL : 29.50 REMARK 200 R MERGE FOR SHELL (I) : 0.79500 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 5.200 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: PDB ENTRY 2FGB REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 48.47 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.39 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 0.2 M SODIUM ACETATE, 20% PEG 3350, PH REMARK 280 7.55, VAPOR DIFFUSION, HANGING DROP, TEMPERATURE 293K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 29.04200 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 48.63200 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 32.05700 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 48.63200 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 29.04200 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 32.05700 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A 1 REMARK 465 ASP A 2 REMARK 465 SER A 3 REMARK 465 GLY A 125 REMARK 465 GLU A 126 REMARK 465 GLU A 127 REMARK 465 LEU A 128 REMARK 465 SER A 129 REMARK 465 PRO A 130 REMARK 465 THR A 131 REMARK 465 ASP A 132 REMARK 465 GLU A 133 REMARK 465 ASN A 134 REMARK 465 GLY A 135 REMARK 465 LYS A 136 REMARK 465 VAL A 137 REMARK 465 GLU A 322 REMARK 465 TYR A 323 REMARK 465 LEU A 324 REMARK 465 GLU A 325 REMARK 465 HIS A 326 REMARK 465 HIS A 327 REMARK 465 HIS A 328 REMARK 465 HIS A 329 REMARK 465 HIS A 330 REMARK 465 HIS A 331 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 LYS A 9 NZ REMARK 470 LYS A 33 CD CE NZ REMARK 470 GLU A 59 CD OE1 OE2 REMARK 470 LYS A 75 CE NZ REMARK 470 LYS A 123 CD CE NZ REMARK 470 ARG A 171 CG CD NE CZ NH1 NH2 REMARK 470 LYS A 201 CD CE NZ REMARK 470 LYS A 225 CG CD CE NZ REMARK 470 LYS A 246 CG CD CE NZ REMARK 470 GLN A 275 CG CD OE1 NE2 REMARK 470 ARG A 278 NE CZ NH1 NH2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND LENGTHS REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,2(A3,1X,A1,I4,A1,1X,A4,3X),1X,F6.3) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 RES CSSEQI ATM2 DEVIATION REMARK 500 HIS A 5 CG HIS A 5 CD2 0.062 REMARK 500 GLU A 58 CD GLU A 58 OE2 -0.078 REMARK 500 HIS A 304 CG HIS A 304 CD2 0.059 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 ARG A 47 NE - CZ - NH2 ANGL. DEV. = -3.0 DEGREES REMARK 500 TYR A 196 CB - CG - CD2 ANGL. DEV. = -3.9 DEGREES REMARK 500 ARG A 223 NE - CZ - NH2 ANGL. DEV. = -4.1 DEGREES REMARK 500 ARG A 263 NE - CZ - NH2 ANGL. DEV. = -3.2 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 SER A 51 -161.29 -127.83 REMARK 500 ALA A 52 148.61 179.02 REMARK 500 PHE A 197 76.19 -162.05 REMARK 500 SER A 221 168.07 76.19 REMARK 500 ARG A 250 -147.47 -122.02 REMARK 500 ARG A 301 27.07 -150.52 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE NAP A 401 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE EDO A 402 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE EDO A 403 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE ACT A 404 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC5 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE PG4 A 405 DBREF 4DZ5 A 1 323 UNP P42330 AK1C3_HUMAN 1 323 SEQADV 4DZ5 PHE A 227 UNP P42330 TRP 227 ENGINEERED MUTATION SEQADV 4DZ5 LEU A 324 UNP P42330 EXPRESSION TAG SEQADV 4DZ5 GLU A 325 UNP P42330 EXPRESSION TAG SEQADV 4DZ5 HIS A 326 UNP P42330 EXPRESSION TAG SEQADV 4DZ5 HIS A 327 UNP P42330 EXPRESSION TAG SEQADV 4DZ5 HIS A 328 UNP P42330 EXPRESSION TAG SEQADV 4DZ5 HIS A 329 UNP P42330 EXPRESSION TAG SEQADV 4DZ5 HIS A 330 UNP P42330 EXPRESSION TAG SEQADV 4DZ5 HIS A 331 UNP P42330 EXPRESSION TAG SEQRES 1 A 331 MET ASP SER LYS HIS GLN CYS VAL LYS LEU ASN ASP GLY SEQRES 2 A 331 HIS PHE MET PRO VAL LEU GLY PHE GLY THR TYR ALA PRO SEQRES 3 A 331 PRO GLU VAL PRO ARG SER LYS ALA LEU GLU VAL THR LYS SEQRES 4 A 331 LEU ALA ILE GLU ALA GLY PHE ARG HIS ILE ASP SER ALA SEQRES 5 A 331 HIS LEU TYR ASN ASN GLU GLU GLN VAL GLY LEU ALA ILE SEQRES 6 A 331 ARG SER LYS ILE ALA ASP GLY SER VAL LYS ARG GLU ASP SEQRES 7 A 331 ILE PHE TYR THR SER LYS LEU TRP SER THR PHE HIS ARG SEQRES 8 A 331 PRO GLU LEU VAL ARG PRO ALA LEU GLU ASN SER LEU LYS SEQRES 9 A 331 LYS ALA GLN LEU ASP TYR VAL ASP LEU TYR LEU ILE HIS SEQRES 10 A 331 SER PRO MET SER LEU LYS PRO GLY GLU GLU LEU SER PRO SEQRES 11 A 331 THR ASP GLU ASN GLY LYS VAL ILE PHE ASP ILE VAL ASP SEQRES 12 A 331 LEU CYS THR THR TRP GLU ALA MET GLU LYS CYS LYS ASP SEQRES 13 A 331 ALA GLY LEU ALA LYS SER ILE GLY VAL SER ASN PHE ASN SEQRES 14 A 331 ARG ARG GLN LEU GLU MET ILE LEU ASN LYS PRO GLY LEU SEQRES 15 A 331 LYS TYR LYS PRO VAL CYS ASN GLN VAL GLU CYS HIS PRO SEQRES 16 A 331 TYR PHE ASN ARG SER LYS LEU LEU ASP PHE CYS LYS SER SEQRES 17 A 331 LYS ASP ILE VAL LEU VAL ALA TYR SER ALA LEU GLY SER SEQRES 18 A 331 GLN ARG ASP LYS ARG PHE VAL ASP PRO ASN SER PRO VAL SEQRES 19 A 331 LEU LEU GLU ASP PRO VAL LEU CYS ALA LEU ALA LYS LYS SEQRES 20 A 331 HIS LYS ARG THR PRO ALA LEU ILE ALA LEU ARG TYR GLN SEQRES 21 A 331 LEU GLN ARG GLY VAL VAL VAL LEU ALA LYS SER TYR ASN SEQRES 22 A 331 GLU GLN ARG ILE ARG GLN ASN VAL GLN VAL PHE GLU PHE SEQRES 23 A 331 GLN LEU THR ALA GLU ASP MET LYS ALA ILE ASP GLY LEU SEQRES 24 A 331 ASP ARG ASN LEU HIS TYR PHE ASN SER ASP SER PHE ALA SEQRES 25 A 331 SER HIS PRO ASN TYR PRO TYR SER ASP GLU TYR LEU GLU SEQRES 26 A 331 HIS HIS HIS HIS HIS HIS HET NAP A 401 48 HET EDO A 402 4 HET EDO A 403 4 HET ACT A 404 4 HET PG4 A 405 13 HETNAM NAP NADP NICOTINAMIDE-ADENINE-DINUCLEOTIDE PHOSPHATE HETNAM EDO 1,2-ETHANEDIOL HETNAM ACT ACETATE ION HETNAM PG4 TETRAETHYLENE GLYCOL HETSYN NAP 2'-MONOPHOSPHOADENOSINE 5'-DIPHOSPHORIBOSE HETSYN EDO ETHYLENE GLYCOL FORMUL 2 NAP C21 H28 N7 O17 P3 FORMUL 3 EDO 2(C2 H6 O2) FORMUL 5 ACT C2 H3 O2 1- FORMUL 6 PG4 C8 H18 O5 FORMUL 7 HOH *186(H2 O) HELIX 1 1 SER A 32 GLY A 45 1 14 HELIX 2 2 ALA A 52 ASN A 56 5 5 HELIX 3 3 ASN A 57 ASP A 71 1 15 HELIX 4 4 LYS A 75 ILE A 79 5 5 HELIX 5 5 TRP A 86 HIS A 90 5 5 HELIX 6 6 ARG A 91 GLU A 93 5 3 HELIX 7 7 LEU A 94 GLN A 107 1 14 HELIX 8 8 ASP A 143 ALA A 157 1 15 HELIX 9 9 ASN A 169 ASN A 178 1 10 HELIX 10 10 ARG A 199 LYS A 209 1 11 HELIX 11 11 VAL A 234 GLU A 237 5 4 HELIX 12 12 ASP A 238 LYS A 249 1 12 HELIX 13 13 THR A 251 ARG A 263 1 13 HELIX 14 14 ASN A 273 VAL A 281 1 9 HELIX 15 15 GLN A 282 PHE A 286 5 5 HELIX 16 16 THR A 289 GLY A 298 1 10 HELIX 17 17 SER A 308 SER A 313 1 6 HELIX 18 18 TYR A 317 ASP A 321 5 5 SHEET 1 A 2 CYS A 7 LYS A 9 0 SHEET 2 A 2 PHE A 15 PRO A 17 -1 O MET A 16 N VAL A 8 SHEET 1 B 9 LEU A 19 GLY A 22 0 SHEET 2 B 9 HIS A 48 ASP A 50 1 O HIS A 48 N PHE A 21 SHEET 3 B 9 PHE A 80 LEU A 85 1 O PHE A 80 N ILE A 49 SHEET 4 B 9 VAL A 111 ILE A 116 1 O LEU A 115 N LEU A 85 SHEET 5 B 9 ALA A 160 SER A 166 1 O LYS A 161 N VAL A 111 SHEET 6 B 9 CYS A 188 GLU A 192 1 O CYS A 188 N VAL A 165 SHEET 7 B 9 VAL A 212 TYR A 216 1 O VAL A 214 N VAL A 191 SHEET 8 B 9 VAL A 266 LYS A 270 1 O VAL A 266 N ALA A 215 SHEET 9 B 9 LEU A 19 GLY A 22 1 N GLY A 20 O VAL A 267 SITE 1 AC1 33 GLY A 22 THR A 23 TYR A 24 ASP A 50 SITE 2 AC1 33 TYR A 55 HIS A 117 SER A 166 ASN A 167 SITE 3 AC1 33 GLN A 190 TYR A 216 SER A 217 ALA A 218 SITE 4 AC1 33 LEU A 219 GLY A 220 SER A 221 GLN A 222 SITE 5 AC1 33 ALA A 253 LEU A 268 ALA A 269 LYS A 270 SITE 6 AC1 33 SER A 271 TYR A 272 ARG A 276 GLN A 279 SITE 7 AC1 33 ASN A 280 ACT A 404 HOH A 501 HOH A 534 SITE 8 AC1 33 HOH A 561 HOH A 586 HOH A 601 HOH A 609 SITE 9 AC1 33 HOH A 649 SITE 1 AC2 5 LYS A 4 PHE A 15 PRO A 17 GLU A 77 SITE 2 AC2 5 HOH A 636 SITE 1 AC3 9 GLN A 6 PRO A 17 VAL A 18 LEU A 19 SITE 2 AC3 9 GLY A 45 PHE A 46 ARG A 47 HIS A 48 SITE 3 AC3 9 PHE A 284 SITE 1 AC4 5 TYR A 55 HIS A 117 NAP A 401 PG4 A 405 SITE 2 AC4 5 HOH A 609 SITE 1 AC5 6 TRP A 86 ASN A 167 PHE A 227 PRO A 318 SITE 2 AC5 6 TYR A 319 ACT A 404 CRYST1 58.084 64.114 97.264 90.00 90.00 90.00 P 21 21 21 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.017216 0.000000 0.000000 0.00000 SCALE2 0.000000 0.015597 0.000000 0.00000 SCALE3 0.000000 0.000000 0.010281 0.00000